SIB-1553A is a nicotinic acetylcholine receptor agonist potentially for the treatment of Alzheimer’s disease (AD). References: Decamp E, Schneider JS. Interaction between nicotinic and dopaminergic therapies on cognition in a chronic Parkinson model. Brain Res. 2009 Mar 25;1262:109-14. doi: 10.1016/j.brainres.2009.01.028. PubMed PMID: 19368843; PubMed Central PMCID: PMC2706019.

纯度：≥98%

CAS：191611-89-9